134
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Investigating the Metabolic Level of Endogenous and Exogenous Substances on the Intervention of Traditional Chinese Medicine Fuzheng Yiliu Decoction in a Rat Orthotopic Liver Cancer Model

, , , , , , & show all
Pages 2785-2801 | Received 29 Jun 2022, Accepted 01 Sep 2022, Published online: 27 Nov 2023

References

  • Xu J, Yang Y. Traditional Chinese medicine in the Chinese health care system. Health Policy. 2009;90(2–3):133–139. doi:10.1016/j.healthpol.2008.09.003
  • Shibata MA, Khan IA, Iinuma MK, et al. Natural products for medicine. J Biomed Biotechnol. 2012;2012:1–7. doi:10.1155/2012/147120
  • Pang WS, Lin SD, Dai QW, Zhang HC, Hu J. Antitussive activity of Pseudostellaria heterophylla (Miq.) Pax extracts and improve in lung function on the multicytokines adjusting. Molecules. 2011;16(4):3360–3370. doi:10.3390/molecules16043360
  • Su BL, Kan YJ, Xie JW, Hu J, Pang WS. Relevance of the pharmacokinetic and pharmacodynamic profiles of Puerariae lobatae radix to aggregation of multi-component molecules in aqueous decoctions. Molecules. 2016;21(7):845. doi:10.3390/molecules21070845
  • Chen JL, Pang WS, Shi WT, et al. Structural elucidation of a novel polysaccharide from Pseudostellaria heterophylla and stimulating glucose uptake in cells and distributing in rats by oral. Molecules. 2016;21(9):1233. doi:10.3390/molecules21091233
  • Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China. Beijing, China: Medical Science and Technology Press; Vol. 1, 2015:15–380.
  • Chen LW, Lin J, Chen W, Zhang WP. Effect of Chinese herbal medicine on patients with primary hepatic carcinoma in III stage during perioperational period: a report of 42 cases. Chin J Integr Tradit West Med. 2005;25:832–834.
  • Zhao HJ, Du J, Chen X, et al. Clinical study of Fuzheng Yiliu recipe combined with microwave ablation on hepatocellular carcinoma. Chin J Integr Tradit West Med. 2013;32:32–34.
  • Chen LW, Du J, Tan JW, Huang ZW. Clinical study of Chinese herbs combined with operation on the primary hepatocarcinoma. J Fujian Coll TCM. 2005;15:6–8.
  • Cao ZY, Du J. Effects of Fuzheng Yiliu decoction on apoptosis related factors expression of H22 tumor-bearing ICR mice. J Fujian Univ TCM. 2013;22:25–28.
  • Hu HX, Cao ZY, Liu ZZ, Chen X, Du J. Effects of Fuzheng Yiliu decoction on expressions of a proliferation-inducing ligand and its receptors in hepatocellular carcinoma tissues. J Fujian Univ TCM. 2011;21:27–29.
  • Zhang YQ, Chen XZ, Cao ZY, Du J. Intervention effect of Fuzheng Yiliu decoction on proliferation and apoptosis of hepatoma HepG2 cells. J Fujian Univ TCM. 2010;20:30–33.
  • Cao ZY, Du J, Chen LW, Liao LM, Zheng LP, Lin W. Influence of Chinese compound prescription on humoral immune in mice with hepatic carcinoma transplanted subcutaneously. J Fujian Coll TCM. 2007;17:33–34.
  • Chen LW, Du J, Dai QW, Zhang HC, Pang WS, Hu J. Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking. Eur J Med Chem. 2014;83:294–306. doi:10.1016/j.ejmech.2014.06.037
  • Zheng CS, Chen LW, Du J, Ye HZ. Study on anti-tumor mechanism of Chinese medicine Fuzhengyiliufufang by molecular docking method. Chin J Clin Pharmacol Ther. 2007;12:892–895.
  • Zheng XF, Tian JS, Liu P, Xing J, Qin XM. Analysis of the restorative effect of Bu-zhong-yi-qi-tang in thespleen-qi deficiency ratmodelusing 1H-NMR-based metabonomics. J Ethnopharmacol. 2014;151(2):912–920. doi:10.1016/j.jep.2013.12.001
  • Wang Y, Li ZF, Chen JX, et al. Study of mini-pig serum of coronary heart disease (Chronic Myocardial I Schemia) with syndrome of blood stasis based on nuclear magnetic resonance metabolomics. Chin J Anal Chem. 2011;39:1274–1278.
  • Shan JJ, Qian WJ, Peng LX, et al. A comparative pharmacokinetic study by UHPLC-MS/MS of main active compounds after oral administration of zushima-gancao extract in normal and adjuvant-induced arthritis rats. Molecules. 2018;23(1):227. doi:10.3390/molecules23010227
  • Pang WS, Yang HW, Wu ZS, Huang MX, Hu J. LC-MS/MS in MRM mode for detection and structural identification of synthetic hypoglycemic drugs added illegally to ‘Natural’ anti-diabetic herbal products. Chromatographia. 2009;70(9–10):1353–1359. doi:10.1365/s10337-009-1344-0
  • Peres RG, Tonin FG, Tavares MFM, Rodriguez-Amaya DB. HPLC-DAD-ESI/MS identification and quantification of phenolic compounds in Ilex paraguariensis beverages and on-line evaluation of individual antioxidant activity. Molecules. 2013;18(4):3859–3871. doi:10.3390/molecules18043859
  • Xu C, Yang Y, Yi SH, Li X, Zhang Q, Chen Gui H. Standardization of rat stable orthotopic liver transplantation model and comparison of the effect of two liver graft perfusion methods. Nan Fang Yi Ke Da Xue Xue Bao. 2006;26(11):1556–1558.
  • Cruz MS, Navoni JA, da Costa Xavier LA, et al. Diosgenin induces genotoxic and mutagenic effects on HepG2 cells. Food Chem Toxicol. 2018;120:98–103. doi:10.1016/j.fct.2018.07.011
  • Choi SI, Jeong CS, Cho SY, Yee YS. Mechanism of apoptosis induced by apigenin in hepG2 human hepatoma cells: involvement of reactive oxygen species generated by NADPH oxidase. Arch Pharm Res. 2007;30(10):1328–1335. doi:10.1007/BF02980274
  • Yao XY, Li GL, Xu H, Lü CT. Inhibition of the JAK-STAT3 signaling pathway by ganoderic acid A enhances chemosensitivity of HepG2 cells to cisplatin. Planta Med. 2012;78(16):1740–1748. doi:10.1055/s-0032-1315303
  • Fu XW, Wang X, Pu WC, XR Li, Wang C. Synthesis and antitumor activities of calycosin and its derivatives. Chin J Synth Chem. 2015;23(3):223–226.
  • Cao ZJ, Cai XY, Fang W, Chen HS, Zhang HN, Zhang YL. Chemical compositions of Cortex Juglans Mandshurica and their activity screening of anti-hepatocarcinoma effect. Shandong Med J. 2014;54(29):1–3.